Report
Damien Conover
EUR 100.00 For Business Accounts Only

Cooper's Product Portfolio Supports a Narrow Moat

We may slightly increase our fair value estimate in response to outpaced revenue growth of Cooper’s surgical business segment versus our projections. Cooper increased its 2019 EPS outlook from $11-30-$11.70 per share to $11.85-$12.18 per share. However, this revision was largely attributable to an abnormally low effective tax rate of 2.6% for the quarter, which was due to favorable internal restructuring and an audit settlement from the United Kingdom. We anticipate the tax rate will increase in...
Underlying
Cooper Companies Inc.

Cooper Companies is a global medical device company. The company operates through CooperVision and CooperSurgical business units. CooperVision is a manufacturer providing products for contact lens wearers. CooperVision designs its products for astigmatism, presbyopia, myopia, ocular dryness and eye fatigues with a collection of spherical, toric and multifocal contact lenses. CooperVision is engaged in myopia management and specialty eye care markets with products, such as orthokeratology and scleral lenses. CooperSurgical focuses on improving the health of women, babies and families through a portfolio of products and services including medical devices, fertility, diagnostics and contraception.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Damien Conover

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch